MWG Biotech / Eurofins Medigenomix develop new software to optimize sequences for gene synthesis

Ebersberg, (PresseBox) - MWG Biotech / Eurofins Medigenomix develop GENEius software with unique features for gene synthesis.

MWG Biotech, through their alliance with Eurofins Medigenomix, has a long track record in synthetic gene production. Based on advanced techniques and optimized processes, the companies offer fast and reliable gene synthesis services, where all process steps including oligonucleotide production, design and processing of gene synthesis and final quality control of the genes are handled in-house.

Several years of experience in gene synthesis was used to develop new sequence optimization algorithms. The resulting software “GENEius”
provides enhanced functions, such as the automatic adaptation of the codon usage, which can optimize DNA sequences for protein expression in a target organism. GENEius also prevents direct or indirect repeats and hairpin structures in the optimized sequence, in that way solving problems during transcription or translation. Unlike other codon adaptation programs, GENEius does not affect codon adaptation quality when optimising for other features.

Dr. Stefan Blickling, Head of Sales Europe, says: “The intelligent features of this sophisticated software help us to strengthen our position as the high quality provider of synthetic genes. It provides us with a tool to design products for our customers, so that they can achieve optimal results from their experiments.”

Eurofins Genomics GmbH

MWG Biotech (ISIN: DE0007300105) ist ein internationaler Anbieter von Genomik-Produkten und Dienstleistungen aus den Bereichen DNA/siRNA Synthese (Produktion synthetischer Genabschnitte) und DNA Sequenzierung (Bestimmung der genetischen Information im Erbgut). Mit starker Kundenorientierung, schnellem Service und qualitativ hochwertigen Produkten aus drei Produktionsstätten in Deutschland, den USA und Indien schafft das Unternehmen die Grundlagen für Erfolg in den Life Science Märkten weltweit.

Press releases you might also be interested in

Weitere Informationen zum Thema "Medizintechnik":

Unternehmen setzen auf KI und Maschine Learning

Ei­ne von So­phos un­ter­stüt­ze ak­tu­el­le IDC-Stu­die zeigt auf, dass 70 Pro­zent der Un­ter­neh­men pla­nen, die­ses Jahr Künst­li­che In­tel­li­genz und Ma­chi­ne Lear­ning (ML) ein­zu­set­zen, um die IT-Si­cher­heit zu ver­bes­sern. Für die IDC-Stu­die wur­den im letz­ten Quar­tal 108 Un­ter­neh­men mit mehr als 1.000 Mit­ar­bei­tern be­fragt.


Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.